A Single-Site Study To Evaluate the Sensitization Potential of Topically Applied ATx201 in Healthy Human Volunteers
Phase of Trial: Phase I
Latest Information Update: 05 Dec 2019
Price : $35 *
At a glance
- Drugs Niclosamide (Primary)
- Indications Atopic dermatitis; Eczema
- Focus Therapeutic Use
- Sponsors UNION Therapeutics
- 04 May 2018 Status changed from recruiting to completed.
- 15 Jan 2018 Status changed from not yet recruiting to recruiting.
- 26 Dec 2017 New trial record